MEDICAMEN BIOTECH Financial Statement Analysis
|
||
|
The Revenues of MEDICAMEN BIOTECH have increased by 27.29% YoY .
The Earnings Per Share (EPS) of MEDICAMEN BIOTECH has decreased by -30.92 % YoY. |
||
MEDICAMEN BIOTECH Last 5 Annual Financial Results
[BOM: 531146|NSE : MEDICAMEQ]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
| Expenses | ₹156 Cr | ₹117 Cr | ₹91 Cr | ₹9,304,488 Cr | ₹106 Cr |
| Operating Profit (Excl OI) | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹1,967,120 Cr | ₹19 Cr |
| Other Income | ₹2.33 Cr | ₹2.46 Cr | ₹1.72 Cr | ₹75,405 Cr | ₹1.94 Cr |
| Interest | ₹5.67 Cr | ₹3.39 Cr | ₹1.94 Cr | ₹151,152 Cr | ₹0.93 Cr |
| Depreciation | ₹7.09 Cr | ₹6.37 Cr | ₹5.77 Cr | ₹251,971 Cr | ₹2.50 Cr |
| Profit Before Tax | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹1,639,401 Cr | ₹18 Cr |
| Profit After Tax | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
| Consolidated Net Profit | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
| Earnings Per Share (Rs) | ₹5.16 | ₹7.47 | ₹11.64 | ₹12.19 | ₹9.93 |
| PAT Margin (%) | 4.03 | 5.29 | 10.46 | 12.90 | 10.76 |
| ROE(%) | 3.23 | 4.94 | 9.13 | 11.25 | 9.89 |
| ROCE(%) | 5.77 | 8.46 | 10.85 | 12.94 | 12.99 |
| Total Debt/Equity(x) | 0.16 | 0.16 | 0.14 | 0.19 | 0.15 |
Key Financials |
||
| Market Cap | : | ₹ 428.6 Cr |
| Revenue (TTM) | : | ₹ 202.6 Cr |
| Net Profit(TTM) | : | ₹ 10.0 Cr |
| EPS (TTM) | : | ₹ 7.4 |
| P/E (TTM) | : | 42.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MEDICAMEN BIOTECH | -2.7% | 21.1% | 2.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -3.2% | -5.4% | 12% |
| DIVIS LABORATORIES | 0.7% | 3.2% | 61.7% |
| TORRENT PHARMACEUTICALS | -2.8% | -3% | 32.6% |
| CIPLA | -2.9% | -3.3% | -10.4% |
| DR REDDYS LABORATORIES | -3.3% | 4.7% | -2.2% |
| MANKIND PHARMA | -2.4% | 6% | 0.8% |
| LUPIN | -1.2% | -4.7% | 4.1% |
| ZYDUS LIFESCIENCES | -3% | 2.2% | 14.7% |
MEDICAMEN BIOTECH Revenues
[BOM: 531146|NSE : MEDICAMEQ]
| Y-o-Y | 27.29 % |
| 5 Yr CAGR | 9.33 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 27.29 | |
| Mar2024 | ₹141 Cr | 22.02 | |
| Mar2023 | ₹115 Cr | -100.00 | |
| Mar2022 | ₹11,271,608 Cr | 8,980,974.92 | |
| Mar2021 | ₹126 Cr | - | |
MEDICAMEN BIOTECH Operating Profit
[BOM: 531146|NSE : MEDICAMEQ]
| Y-o-Y | -3.39 % |
| 5 Yr CAGR | 4.83 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | -3.39 | |
| Mar2024 | ₹24 Cr | 1.05 | |
| Mar2023 | ₹24 Cr | -100.00 | |
| Mar2022 | ₹1,967,120 Cr | 10,102,201.61 | |
| Mar2021 | ₹19 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -24.13 % |
| 5 Yr CAGR | -4.13 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 13.11% | -24.13 | |
| Mar2024 | 17.28% | -17.16 | |
| Mar2023 | 20.86% | 19.54 | |
| Mar2022 | 17.45% | 12.44 | |
| Mar2021 | 15.52% | - | |
MEDICAMEN BIOTECH Profit After Tax
[BOM: 531146|NSE : MEDICAMEQ]
| Y-o-Y | -35.54 % |
| 5 Yr CAGR | -8.07 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.49 Cr | -35.54 | |
| Mar2024 | ₹15 Cr | -1.13 | |
| Mar2023 | ₹15 Cr | -100.00 | |
| Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
| Mar2021 | ₹13 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -23.82 % |
| 5 Yr CAGR | -21.77 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 4.03 % | -23.82 | |
| Mar2024 | 5.29 % | -49.43 | |
| Mar2023 | 10.46 % | -18.91 | |
| Mar2022 | 12.9 % | 19.89 | |
| Mar2021 | 10.76 % | - | |
MEDICAMEN BIOTECH Earnings Per Share (EPS)
[BOM: 531146|NSE : MEDICAMEQ]
| Y-o-Y | -30.92 % |
| 5 Yr CAGR | -15.10 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.16 | -30.92 | |
| Mar2024 | ₹7.47 | -35.82 | |
| Mar2023 | ₹12 | -4.51 | |
| Mar2022 | ₹12 | 22.76 | |
| Mar2021 | ₹9.93 | - | |
MEDICAMEN BIOTECH Return on Capital Employed (ROCE)
[BOM: 531146|NSE : MEDICAMEQ]
| Y-o-Y | -31.80 % |
| 5 Yr CAGR | -18.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 5.77% | -31.80 | |
| Mar2024 | 8.46% | -22.03 | |
| Mar2023 | 10.85% | -16.15 | |
| Mar2022 | 12.94% | -0.38 | |
| Mar2021 | 12.99% | - | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹315.2 |
| Current MarketCap | : | ₹ 428.6 Cr |
| Updated EOD on | : | Oct 06,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -2.7% |
21.1% |
2.7% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
MEDICAMEN BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -4.4% | -3.8% | 12.2% |
No NSE index found
You may also like the below Video Courses
FAQ about MEDICAMEN BIOTECH Financials
How the annual revenues of MEDICAMEN BIOTECH have changed ?
The Revenues of MEDICAMEN BIOTECH have increased by 27.29% YoY .
How the Earnings per Share (EPS) of MEDICAMEN BIOTECH have changed?
The Earnings Per Share (EPS) of MEDICAMEN BIOTECH has decreased by -30.92 % YoY .
Check out Intrinsic Value of Peers of MEDICAMEN BIOTECH
Compare Stock Analytics of Peers of MEDICAMEN BIOTECH
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
